Daniel Martins-de-Souza
CV Lattes
GoogleMyCitations
ResearcherID
ORCID
Universidade Estadual de Campinas (UNICAMP). Instituto de Biologia (IB) (Institutional affiliation for the last research proposal) Birthplace: Brazil
Daniel Martins-de-Souza is Associate Professor of Biochemistry at the University of Campinas (UNICAMP), Brazil, where he obtained a BSc in Biology and a PhD in Biochemistry. The proteome of schizophrenia was the subject of his PhD thesis, which he continued to study during his postdoctoral training in the Max Planck Institute of Psychiatry, Germany and also in the University of Cambridge, UK. He headed the Neuroproteomics Unit of the Dept. of Psychiatry and Psychotherapy of the Ludwig Maximilians University (LMU) Munich, Germany before returning to Brazil in 2014. Back to UNICAMP, Daniel founded the Laboratory of Neuroproteomics funded by the São Paulo Research Foundation (FAPESP) via a Young Investigator Grant. Daniel´s lab employs proteomic tools to investigate molecular mechanisms involved in psychiatric disorders and the identification of potential biomarkers. He is Associated Editor for npj Schizophrenia (Nature), founding member of the Brazilian Society of Proteomics and part of the board of the Brazilian Society of Mass Spectrometry. It was part of the board of the Human Proteome Organization (HUPO) 2015-2017. In 2016, Daniel was elected as Affiliated Member of the Brazilian Academy of Sciences and in 2019, was elected as Member of the São Paulo Academy of Sciences. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| Consortium vows to find new drugs against Chagas disease, leishmaniosis and malaria |
- Multi-User Equipment approved in grant 2017/25588-1: cromatógrafo Acquity UPLC I-Class, AP.EMU
Abstract
This equipment will enable the establishment of a lipidomic platform for the study of brain diseases, in particular psychiatric disorders. This equipment will be combined with the mass spectrometer also funded by FAPESP (2014 / 10068-4). (AU)
- From the basic understanding to clinical biomarkers to schizophrenia: a neuroproteomics-centered multidisciplinary study, AP.TEM
Abstract
Schizophrenia is among the most disabling diseases of humankind, affecting 1% of the world's population (in Brazil, almost 2.5 million people are affected). One of the biggest hurdles faced by most patients is the poor efficacy of current antipsychotic medication. This stems from the lack of understanding of schizophrenia's pathobiology and the lack of biomarkers and biological mechanis...
- Biochemical effects of cannabinoids on oligodendrocytes: implications for schizophrenia, AP.R
Abstract
nd to discover possible therapeutic agents for this process. Studies indicate that the modulation of the endocannabinoid system in oligodendrocytes can affect important biological processes. Thus, the aim of this project will evaluate several pharmacological manipulations of the endocannabinoid system in human culture of oligodendrocytes (MO3.13), and in the differentiation process of t...
- Multi-User Equipment approved in grant 13/08711-3: mass spectrometer waters SYNAPT G2-Si HDMS + nanoACQUITY UPLC, AP.EMU
Abstract
A mass spectrometer is the central core of a proteomics laboratory. Proteomic analyses depend 100% on a mass spectrometer. The equipment proposed is pivotal for the success of the project 13/08711-3 funded by FAPESP. All steps proposed by this project as well as collaborations regarding proteomic analyses in all senses depend heavily on this equipment: protein identification, quantifica...
- Developing a predictive test for a successful medication response and understanding the molecular bases of schizophrenia through proteomics, AP.JP
Abstract
Schizophrenia is an incurable and debilitating mental disorder which affects approximately 1% of world population. It is a multifactorial disease involving exogenous and endogenous factors since the neurodevelopment. The molecular mechanisms of the disease are still to be unraveled for an integrated comprehension of the pathobiology. Additionally, biomarkers for diagnosis and for the li...
- Study of metabolic syndrome on clozapine treated adipocytes, BP.DR
Abstract
Schizophrenia is an incurable psychiatric illness that affects about 1% of the world's population. The symptoms usually appear in adult life and are divided into three categories: positive symptoms (hallucinations and delusions); negative symptoms (unsociability, depression and lack of motivation); and cognitive problems (difficulty concentrating, impaired executive functions and long-t...
- Maintaining and maturing oligodendrocyte cell line, BP.TT
- Effects of homcysteine and its cofactors on the proteome of oligodendrocytes and possible implications in schizophrenia, BP.MS
Abstract
Schizophrenia is a serious psychiatric disorder involving genetic and environmental factors. Early symptoms usually occur between late youth and early adulthood, and are classified as positive, negative and cognitive symptoms. Several hypotheses describe the pathophysiology of schizophrenia, such as the dopaminergic and glutamatergic ones. The dopaminergic hypothesis is related to the m...
(Only some records are available in English at this moment)
- Proteome modulation by cannabinoid drugs in human oligodendrocytes, BP.TT
- Identification of blood-based biomarkers for late-life depression through proteomics, BP.MS
Abstract
Depression is a debilitating disorder and the biggest cause of suicide in the world. It is a complex and multifactorial disease, as well as being a common comorbidity in serious pathologies, including Alzheimer's disease. The peculiarities of depression in adults over 55 years form a heterogeneous syndrome called Late-life Depression (LLD), which affects about 6.5% of the world's elderl...
- Establishment of the hnRNPs role on schizophrenia through protein interaction network mapping, BP.PD
Abstract
Schizophrenia consists on a chronic psychiatric disorder reaching 1% of world population. It is a multifactorial disease resulting of environmental and genetic factors. The pathology molecular mechanisms are mostly unknown, therefore several methodologies such as GWAS, transcriptome and proteome has been used to study and better understand the molecular basis concerning schizophrenia.Ou...
(Only some records are available in English at this moment)
- Role of cannabinoids in induced pluripotent stem cell-derived oligodendrocytes from schizophrenia patients, BE.EP.PD
Abstract
The pathophysiology of schizophrenia (SCZ) is highly complex and involves several neurotransmission systems. Recently, the endocannabinoid system has been investigated in this field, and cannabinoids (endocannabinoids, phytocannabinoids and synthetic cannabinoids) seem to be a potential target to treat SCZ. Additionally, abnormalities in glia cells - especially oligodendrocytes (OLs) - ...
- In vivo cross-linking: a more comprehensive way to determine protein-protein interactions, BE.EP.PD
Abstract
Chemical cross-linking coupled to mass spectrometry (XLMS) is a great tool to investigate protein-protein interaction. In this technique, in vitro complexes are reacted with cross-linkers and the linkage sites are latter reliably identified by mass spectrometry. Although this technique has been used successfully to map protein interactions in cases of stable, high affinity complexes, th...
- The role of D-Serine in the cellular communication between neurons and astrocytes during neurodevelopment, BE.EP.DR
Abstract
Schizophrenia is an incurable mental disorder that affects 1% of the world population and is among the most disabling human diseases. On average, 70% of patients abandon medication due to its low efficacy and the presence of severe side effects. To change these conditions, it is necessary to understand the pathophysiology of schizophrenia at the molecular level. Besides the long-establi...
(Only some records are available in English at this moment)
| 3 / 3 | Ongoing research grants |
| 3 / 2 | Completed research grants |
| 9 / 9 | Ongoing scholarships in Brazil |
| 17 / 12 | Completed scholarships in Brazil |
| 4 / 4 | Completed scholarships abroad |
| 36 / 30 | All research grants and scholarships |
| Associated processes | |
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
| Publications | 37 |
| Citations | 887 |
| Cit./Article | 24.0 |
| Data from Web of Science | |
CASSOLI, JULIANA S.; GUEST, PAUL C.; SANTANA, ALINE G.; MARTINS-DE-SOUZA, DANIEL. Employing proteomics to unravel the molecular effects of antipsychotics and their role in schizophrenia. PROTEOMICS CLINICAL APPLICATIONS, v. 10, n. 4, SI, p. 442-455, APR 2016. Web of Science Citations: 5.
STEINER, JOHANN; MARTINS-DE-SOUZA, DANIEL; SCHILTZ, KOLJA; SARNYAI, ZOLTAN; WESTPHAL, SABINE; ISERMANN, BEREND; DOBROWOLNY, HENRIK; TURCK, CHRISTOPH W.; BOGERTS, BERNHARD; BERNSTEIN, HANS-GERT; et al. Clozapine promotes glycolysis and myelin lipid synthesis in cultured oligodendrocytes. FRONTIERS IN CELLULAR NEUROSCIENCE, v. 8, NOV 18 2014. Web of Science Citations: 18.
SAIA-CEREDA, VERONICA M.; CASSOLI, JULIANA S.; SCHMITT, ANDREA; FALKAI, PETER; NASCIMENTO, JULIANA M.; MARTINS-DE-SOUZA, DANIEL. Proteomics of the corpus callosum unravel pivotal players in the dysfunction of cell signaling, structure, and myelination in schizophrenia brains. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, v. 265, n. 7, p. 601-612, OCT 2015. Web of Science Citations: 29.
MARTINS-DE-SOUZA, DANIEL; CASSOLI, JULIANA S.; NASCIMENTO, JULIANA M.; HENSLEY, KENNETH; GUEST, PAUL C.; PINZON-VELASCO, ANDRES M.; TURCK, CHRISTOPH W.. The protein interactome of collapsin response mediator protein-2 (CRMP2/DPYSL2) reveals novel partner proteins in brain tissue. PROTEOMICS CLINICAL APPLICATIONS, v. 9, n. 9-10, SI, p. 817-831, OCT 2015. Web of Science Citations: 18.
OLIVEIRA, BRUNO M.; COORSSEN, JENS R.; MARTINS-DE-SOUZA, DANIEL. 2DE: The Phoenix of Proteomics. JOURNAL OF PROTEOMICS, v. 104, n. SI, p. 140-150, JUN 2 2014. Web of Science Citations: 61.
CAFE-MENDES, C. C.; FERRO, E. S.; TORRAO, A. S.; CRUNFLI, F.; RIOLI, V.; SCHMITT, A.; FALKAI, P.; BRITTO, L. R.; TURCK, C. W.; MARTINS-DE-SOUZA, D.. Peptidomic analysis of the anterior temporal lobe and corpus callosum from schizophrenia patients. JOURNAL OF PROTEOMICS, v. 151, n. SI, p. 97-105, JAN 16 2017. Web of Science Citations: 10.
DAKIC, VANJA; MACIER, RENATA DE MORAES; DRUMMOND, HANNAH; NASCIMENTO, JULIANA M.; TRINDADE, PABLO; REHEN, STEVENS K.. Harmine stimulates proliferation of human neural progenitors. PeerJ, v. 4, DEC 6 2016. Web of Science Citations: 14.
VENDRAMINI, PEDRO H.; GATTAZ, WAGNER F.; SCHMITT, ANDREA; FALKAI, PETER; EBERLIN, MARCOS N.; MARTINS-DE-SOUZA, DANIEL. Pioneering ambient mass spectrometry imaging in psychiatry: Potential for new insights into schizophrenia. SCHIZOPHRENIA RESEARCH, v. 177, n. 1-3, p. 67-69, NOV 2016. Web of Science Citations: 6.
SAIA-CEREDA, VERONICA M.; CASSOLI, JULIANA S.; SCHMITT, ANDREA; FALKAI, PETER; MARTINS-DE-SOUZA, DANIEL. Differential proteome and phosphoproteome may impact cell signaling in the corpus callosum of schizophrenia patients. SCHIZOPHRENIA RESEARCH, v. 177, n. 1-3, p. 70-77, NOV 2016. Web of Science Citations: 8.
DAKIC, VANJA; NASCIMENTO, JULIANA MINARDI; SARTORE, RAFAELA COSTA; MACIEL, RENATA DE MORAES; DE ARAUJO, DRAULIO B.; RIBEIRO, SIDARTA; MARTINS-DE-SOUZA, DANIEL; REHEN, STEVENS K.. Short term changes in the proteome of human cerebral organoids induced by 5-MeO-DMT. SCIENTIFIC REPORTS, v. 7, OCT 9 2017. Web of Science Citations: 10.
GUEST, PAUL C.; IWATA, KEIKO; KATO, TAKAHIRO A.; STEINER, JOHANN; SCHMITT, ANDREA; TURCK, CHRISTOPH W.; MARTINS-DE-SOUZA, DANIEL. MK-801 treatment affects glycolysis in oligodendrocytes more than in astrocytes and neuronal cells: insights for schizophrenia. FRONTIERS IN CELLULAR NEUROSCIENCE, v. 9, MAY 12 2015. Web of Science Citations: 20.
SAIA-CEREDA, VERONICA M.; CASSOLI, JULIANA S.; MARTINS-DE-SOUZA, DANIEL; NASCIMENTO, JULIANA M.. Psychiatric disorders biochemical pathways unraveled by human brain proteomics. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, v. 267, n. 1, p. 3-17, FEB 2017. Web of Science Citations: 9.
GUEST, PAUL C.; GUEST, FRANCESCA L.; MARTINS-DE SOUZA, DANIEL. Making Sense of Blood-Based Proteomics and Metabolomics in Psychiatric Research. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, v. 19, n. 6, JUN 2016. Web of Science Citations: 19.
SUSSULINI, ALESSANDRA; ERBOLATO, HELENA MUNHOZ; PESSOA, GUSTAVO DE SOUZA; ZEZZI ARRUDA, MARCO AURELIO; STEINER, JOHANN; MARTINS-DE-SOUZA, DANIEL. Elemental fingerprinting of schizophrenia patient blood plasma before and after treatment with antipsychotics. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, v. 268, n. 6, p. 565-570, SEP 2018. Web of Science Citations: 0.
CASSOLI, JULIANA SILVA; GUEST, PAUL C.; MALCHOW, BEREND; SCHMITT, ANDREA; FALKAI, PETER; MARTINS-DE-SOUZA, DANIEL. Disturbed macro-connectivity in schizophrenia linked to oligodendrocyte dysfunction: from structural findings to molecules. NPJ SCHIZOPHRENIA, v. 1, 2015. Web of Science Citations: 21.
MARTINS-DE-SOUZA, DANIEL; SOLARIA, FIORELLA A.; GUEST, PAUL C.; ZAHEDI, RENE P.; STEINER, JOHANN. Biological pathways modulated by antipsychotics in the blood plasma of schizophrenia patients and their association to a clinical response. NPJ SCHIZOPHRENIA, v. 1, 2015. Web of Science Citations: 6.
SANTOS DE OLIVEIRA, PERCILLIA VICTORIA; GARCIA-ROSA, SHEILA; AZEVEDO SACHETTO, ANA TERESA; SOARES MORETTI, ANA IOCHABEL; DEBBAS, VICTOR; DE BESSA, TIPHANY CORALIE; SILVA, NATHALIA TENGUAN; PEREIRA, ALEXANDRE DA COSTA; MARTINS-DE-SOUZA, DANIEL; SANTORO, MARCELO LARAMI; et al. Protein disulfide isomerase plasma levels in healthy humans reveal proteomic signatures involved in contrasting endothelial phenotypes. REDOX BIOLOGY, v. 22, APR 2019. Web of Science Citations: 0.
DEZONNE, ROMULO SPERDUTO; SARTORE, RAFAELA COSTA; NASCIMENTO, JULIANA MINARDI; SAIA-CEREDA, VERONICA M.; ROMAO, LUCIANA FERREIRA; ALVES-LEON, SONIZA VIEIRA; DE SOUZA, JORGE MARCONDES; MARTINS-DE-SOUZA, DANIEL; REHEN, STEVENS KASTRUP; ALCANTARA GOMES, FLVIA CARVALHO. Derivation of Functional Human Astrocytes from Cerebral Organoids. SCIENTIFIC REPORTS, v. 7, MAR 27 2017. Web of Science Citations: 16.
RUBIO, MARCELO VENTURA; FANCHINI TERRASAN, CESAR RAFAEL; CONTESINI, FABIANO JARES; ZUBIETA, MARIANE PALUDETTI; GERHARDT, JAQUELINE ALINE; OLIVEIRA, LEANDRO CRISTANTE; DE SOUZA SCHMIDT GONCALVES, ANY ELISA; ALMEIDA, FAUSTO; SMITH, BRADLEY JOSEPH; MARTINS FERREIRA DE SOUZA, GUSTAVO HENRIQUE; et al. Redesigning N-glycosylation sites in a GH3 beta-xylosidase improves the enzymatic efficiency. BIOTECHNOLOGY FOR BIOFUELS, v. 12, n. 1, NOV 14 2019. Web of Science Citations: 0.
AQUINO, ADRIANO; ALEXANDRINO, GUILHERME L.; GUEST, PAUL C.; AUGUSTO, FABIO; GOMES, ALEXANDRE F.; MURGU, MICHAEL; STEINER, JOHANN; MARTINS-DE-SOUZA, DANIEL. Blood-Based Lipidomics Approach to Evaluate Biomarkers Associated With Response to Olanzapine, Risperidone, and Quetiapine Treatment in Schizophrenia Patients. FRONTIERS IN PSYCHIATRY, v. 9, MAY 25 2018. Web of Science Citations: 2.
NASCIMENTO, JULIANA M.; GARCIA, SHEILA; SAIA-CEREDA, VERONICA M.; SANTANA, ALINE G.; BRANDAO-TELES, CAROLINE; ZUCCOLI, GIULIANA S.; JUNQUEIRA, DANIELLE G.; REIS-DE-OLIVEIRA, GUILHERME; BALDASSO, PAULO A.; CASSOLI, JULIANA S.; et al. Proteomics and molecular tools for unveiling missing links in the biochemical understanding of schizophrenia. PROTEOMICS CLINICAL APPLICATIONS, v. 10, n. 12, SI, p. 1148-1158, DEC 2016. Web of Science Citations: 4.
STEINER, JOHANN; SCHMITT, ANDREA; SCHROETER, MATTHIAS L.; BOGERTS, BERNHARD; FALKAI, PETER; TURCK, CHRISTOPH W.; MARTINS-DE-SOUZA, DANIEL. S100B is downregulated in the nuclear proteome of schizophrenia corpus callosum. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, v. 264, n. 4, p. 311-316, JUN 2014. Web of Science Citations: 10.
GARCEZ, PATRICIA P.; LOIOLA, ERICK CORREIA; DA COSTA, RODRIGO MADEIRO; HIGA, LUIZA M.; TRINDADE, PABLO; DELVECCHIO, RODRIGO; NASCIMENTO, JULIANA MINARDI; BRINDEIRO, RODRIGO; TANURI, AMILCAR; REHEN, STEVENS K.. Zika virus impairs growth in human neurospheres and brain organoids. Science, v. 352, n. 6287, p. 816-818, MAY 13 2016. Web of Science Citations: 442.
ZUCCOLI, GIULIANA S.; SAIA-CEREDA, VERONICA M.; NASCIMENTO, JULIANA M.; MARTINS-DE-SOUZA, DANIEL. The Energy Metabolism Dysfunction in Psychiatric Disorders Postmortem Brains: Focus on Proteomic Evidence. FRONTIERS IN NEUROSCIENCE, v. 11, SEP 7 2017. Web of Science Citations: 12.
TAVARES, RAPHAEL; WAJNBERG, GABRIEL; SCHERER, NICOLE DE MIRANDA; PAULETTI, BIANCA ALVES; CASSOLI, JULIANA S.; FERREIRA, CARLOS GIL; PAES LEME, ADRIANA FRANCO; DE ARAUJO-SOUZA, PATRICIA SAVIO; MARTINS-DE-SOUZA, DANIEL; PASSETTI, FABIO. Unveiling alterative splice diversity from human oligodendrocyte proteome data. JOURNAL OF PROTEOMICS, v. 151, n. SI, p. 293-301, JAN 16 2017. Web of Science Citations: 3.
CASSOLI, JULIANA S.; BRANDAO-TELES, CAROLINE; SANTANA, ALINE G.; SOUZA, GUSTAVO H. M. F.; MARTINS-DE-SOUZA, DANIEL. Ion Mobility-Enhanced Data-Independent Acquisitions Enable a Deep Proteomic Landscape of Oligodendrocytes. PROTEOMICS, v. 17, n. 21, NOV 2017. Web of Science Citations: 4.
SCHMITT, ANDREA; MARTINS-DE-SOUZA, DANIEL; AKBARIAN, SCHAHRAM; CASSOLI, JULIANA S.; EHRENREICH, HANNELORE; FISCHER, ANDRE; FONTEH, ALFRED; GATTAZ, WAGNER F.; GAWLIK, MICHAEL; GERLACH, MANFRED; et al. Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, v. 18, n. 5, p. 330-356, 2017. Web of Science Citations: 8.
GARCEZ, PATRICIA P.; NASCIMENTO, JULIANA MINARDI; DE VASCONCELOS, JANAINA MOTA; DA COSTA, RODRIGO MADEIRO; DELVECCHIO, RODRIGO; TRINDADE, PABLO; LOIOLA, ERICK CORREIA; HIGA, LUIZA M.; CASSOLI, JULIANA S.; VITORIA, GABRIELA; et al. Zika virus disrupts molecular fingerprinting of human neurospheres. SCIENTIFIC REPORTS, v. 7, JAN 23 2017. Web of Science Citations: 33.
MARTINS-DE-SOUZA, DANIEL. Proteomics, metabolomics, and protein interactomics in the characterization of the molecular features of major depressive disorder. DIALOGUES IN CLINICAL NEUROSCIENCE, v. 16, n. 1, p. 63-73, MAR 2014. Web of Science Citations: 35.
CASSOLI, JULIANA S.; IWATA, KEIKO; STEINER, JOHANN; GUEST, PAUL C.; TURCK, CHRISTOPH W.; NASCIMENTO, JULIANA M.; MARTINS-DE-SOUZA, DANIEL. Effect of MK-801 and Clozapine on the Proteome of Cultured Human Oligodendrocytes. FRONTIERS IN CELLULAR NEUROSCIENCE, v. 10, MAR 3 2016. Web of Science Citations: 14.
BRANDAO-TELES, CAROLINE; DE ALMEIDA, VALERIA; CASSOLI, JULIANA S.; MARTINS-DE-SOUZA, DANIEL. Oligodendrocytes: Potential of Discovering New Treatment Targets. FRONTIERS IN PHARMACOLOGY, v. 10, MAR 5 2019. Web of Science Citations: 1.
TURCK, CHRISTOPH W.; GUEST, PAUL C.; MACCARRONE, GIUSEPPINA; ISING, MARCUS; KLOIBER, STEFAN; LUCAE, SUSANNE; HOLSBOER, FLORIAN; MARTINS-DE-SOUZA, DANIEL. Proteomic Differences in Blood Plasma Associated with Antidepressant Treatment Response. FRONTIERS IN MOLECULAR NEUROSCIENCE, v. 10, AUG 31 2017. Web of Science Citations: 3.
NASCIMENTO, JULIANA M.; MARTINS-DE-SOUZA, DANIEL. The proteome of schizophrenia. NPJ SCHIZOPHRENIA, v. 1, 2015. Web of Science Citations: 37.
DE ALMEIDA, VALERIA; MARTINS-DE-SOUZA, DANIEL. Cannabinoids and glial cells: possible mechanism to understand schizophrenia. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, v. 268, n. 7, p. 727-737, OCT 2018. Web of Science Citations: 2.
SEABRA, GABRIELA; FALVELLA, ANA CAROLINE B.; GUEST, PAUL C.; MARTINS-DE-SOUZA, DANIEL; DE ALMEIDA, VALERIA. Proteomics and Lipidomics in the Elucidation of Endocannabinoid Signaling in Healthy and Schizophrenia Brains. PROTEOMICS, v. 18, n. 18, SI, SEP 2018. Web of Science Citations: 0.
NOWILL, ALEXANDRE E.; FORNAZIN, MARCIA C.; SPAGO, MARIA C.; DORGAN NETO, VICENTE; PINHEIRO, VITORIA R. P.; ALEXANDRE, SIMONIA S. S.; MORAES, EDGAR O.; SOUZA, GUSTAVO H. M. F.; EBERLIN, MARCOS N.; MARQUES, LYGIA A.; et al. Immune Response Resetting in Ongoing Sepsis. JOURNAL OF IMMUNOLOGY, v. 203, n. 5, p. 1298-1312, SEP 1 2019. Web of Science Citations: 0.
VELASQUEZ, ERIKA; NOGUEIRA, FABIO C. S.; VELASQUEZ, INGRID; SCHRNITT, ANDREA; FALKAI, PETER; DOMONT, GILBERTO B.; MARTINS-DE-SOUZA, DANIEL. Synaptosomal Proteome of the Orbitofrontal Cortex from Schizophrenia Patients Using Quantitative Label-Free and iTRAQ-Based Shotgun Proteomics. JOURNAL OF PROTEOME RESEARCH, v. 16, n. 12, p. 4481-4494, DEC 2017. Web of Science Citations: 7.
(References retrieved automatically from State of São Paulo Research Institutions)
TELES, Caroline Brandão. Empregando a proteômica para compreender os mecanismos de ação dos antipsicóticos em oligodendrócitos humanos : Employing proteomics to understand the mechanisms of action of antipsychotics in human oligodendrocytes. 2018. Dissertação (Mestrado) -
MARTINS-DE-SOUZA, Daniel. Determinação do perfil de expressão genica e proteomica em tecido cerebral de pacientes esquizofrenicos. 2008. Tese (Doutorado) – Instituto de Biologia. Universidade Estadual de Campinas (UNICAMP).
ZUCCOLI, Giuliana da Silva. Caracterização do proteoma mitocondrial e nuclear de células neurais derivadas de iPSCs de pacientes com esquizofrenia : Characterization of the mitochondrial and nuclear proteome of neural cells derived from iPSCs from schizophrenia patients. 2018. Dissertação (Mestrado) -
Solicitação em análise e dentro do prazo legal de sigilo previsto na legislação BR1020170258521 - Universidade Estadual de Campinas (UNICAMP). Solicitação em análise e dentro do prazo legal de sigilo previsto na legislação - November 2017, 30